Maria Soledad Esposito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maria Soledad Esposito has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Alexia Lantheaume
Institute of Clinical Neurobiology, University Hospital Wuerzburg
1 shared publicationAngela Isabel Tissone
Centro Atomico Bariloche
1 shared publicationChi Wang Ip
University Hospital of Wuerzburg
1 shared publicationDennis Doll
Institute of Clinical Neurobiology, University Hospital Wuerzburg
1 shared publicationJérémy Signoret-Genest
Institute of Clinical Neurobiology, University Hospital Wuerzburg
1 shared publicationKilian Katzenberger
Institute of Clinical Neurobiology, University Hospital Wuerzburg
1 shared publication
Latest Publications
- Open Access
A viral vector model for circuit-specific synucleinopathy
In Parkinson’s disease (PD), pathomechanisms such as aberrant network dysfunctions can be elucidated by conducting multiscale explorations in animal models. However, the lack of specificity in the existing models limits a restricted targeting of individual network elements and characterization of PD as a “circuitopathy”. We therefore developed a cell-type specific viral vector (AAV2/9-Cre ON -A53T-αSyn) mouse model that allows to induce synucleinopathy within individual circuit elements in vivo . When specifically targeted to dopaminergic (DA) neurons of the substantia nigra pars compacta (SNc), our approach recapitulates the main hallmarks of the disease, namely Lewy-body-like aggregation, progressive cellular and nigrostriatal projections loss, together with locomotor impairment. Our strategy is supported by new state-of-the-art analytical approaches for cell quantification and behavior characterization. Altogether, we provide a novel model of synucleinopathy, which offers new opportunities to study the contribution of individual network elements to disease pathomechanisms.
Open AccessA viral vector model for circuit-specific synucleinopathy
In Parkinson’s disease (PD), pathomechanisms such as aberrant network dysfunctions can be elucidated by conducting multiscale explorations in animal models. However, the lack of specificity in the existing models limits a restricted targeting of individual network elements and characterization of PD as a “circuitopathy”. We therefore developed a cell-type specific viral vector (AAV2/9-Cre ON -A53T-αSyn) mouse model that allows to induce synucleinopathy within individual circuit elements in vivo . When specifically targeted to dopaminergic (DA) neurons of the substantia nigra pars compacta (SNc), our approach recapitulates the main hallmarks of the disease, namely Lewy-body-like aggregation, progressive cellular and nigrostriatal projections loss, together with locomotor impairment. Our strategy is supported by new state-of-the-art analytical approaches for cell quantification and behavior characterization. Altogether, we provide a novel model of synucleinopathy, which offers new opportunities to study the contribution of individual network elements to disease pathomechanisms.